Mucosal tissue injury in cancer therapy: More than mucositis and mouthwash

Cancer Practice

Volumn 10, Issue 4, 2002, Pages 179-191

  McGuire, Deborah B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemotherapy; Mucosal tissue injury; Mucositis; Radiation therapy; Side effect; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER RESEARCH; CANCER THERAPY; CLINICAL FEATURE; CLINICAL PRACTICE; GENETIC ANALYSIS; HEALTH CARE POLICY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; MOUTHWASH; MUCOSA INFLAMMATION; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PROBLEM SOLVING; RISK FACTOR; TISSUE INJURY;

ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; HUMANS; INTESTINAL MUCOSA; MOUTH MUCOSA; MUCOUS MEMBRANE; PAIN; STOMATITIS; VIRUS DISEASES;

EID: 0036311280     PISSN: 10654704     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5394.2002.104009.x     Document Type: Article

References (88)

1. Factors influencing oral mucositis in patients receiving chemotherapy
2. Descriptions and incidence of oral complications
3. Pain and psychological distress in patients undergoing autologous bone marrow transplantation
4. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation
5. Acute oral pain and mucositis in bone marrow transplant and leukemia patients: Data from a pilot study
6. Oral mucositis in patients treated with chemotherapy for solid tumors: A retrospective analysis of 150 cases
7. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients
8. Protection against mucosal injury by growth factors and cytokines
9. Oral problems in supportive care: No longer an orphan topic?
10. Mucositis
11. Oral complications from cancer therapy: Part 1. Pathophysiology and secondary complications
12. Consensus development conference on oral complications of cancer therapies: Diagnosis, prevention, and treatment
13. Oral toxicity
14. Oral health care for the cancer patient
15. Integumentary and mucous membrane alterations
16. Mucosal injury in cancer patients: New strategies for research and treatment
17. Management of dry mouth
18. A survey of mouth pain and dryness in patients with advanced cancer
19. Infection and mucosal injury in cancer treatment
20. Biology of oral mucosa and esophagus
21. The surface area of the adult human mouth and the thickness of the salivary film covering the teeth and oral mucosa
22. Anatomy and physiology of the esophagus
23. Establishment of oral mucosa phenotype in vitro in correlation to epithelial anchorage
24. Interspecies variations in oral epithelial cytokeratin expression
25. Esophageal submucosal glands: Structure and function
26. A transgenic mouse model of intestine-specific mucosal injury and repair
27. Inflammatory cytokines and mucosal injury
28. Mapping dynamic epithelial cell proliferative activity within the oral cavity of man: A new insight into carcinogenesis
29. Penetration pathways of different compounds through epidermis and oral epithelia
30. Oral mucosa
31. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity
32. Keratinocytes and cytokine/growth factors
33. Role of epidermal growth factor (EGF) in oesophageal mucosal integrity
34. Proliferative and apoptotic responses in cancers with special reference to oral cancers
35. Circadian variation in the expression of cell-cycle proteins in human oral epithelium
36. Risk factors for chemotherapy-induced oral mucositis: Dental appliances, oral hygiene, previous oral lesions, and history of smoking
37. Factors influencing oral cavity status during high-dose antineoplastic therapy: A secondary data analysis
38. Routes of drug transport across oral mucosa
39. Biophysical kinetic modeling of buccal absorption
40. Salivary mucins: Their role in oral mucosal barrier function and delivery
41. Human salivary histatins: Promising anti-fungal therapeutic agents
42. Epithelial antimicrobial peptides: Review and significance for oral applications
43. Permeability of oral mucosa and skin with age
44. Effect of age on the dynamics of human gingival microcirculation
45. Effects of aging on the microvasculature and microcirculation in skin and oral mucosa
46. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy
47. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation
48. Biology of mucosal pain
49. Oral mucositis in cancer patients
50. Profiles of pain in bone marrow/stem cell transplantation and leukemia patients
51. Peripheral mechanisms of inflammatory pain
52. Pain due to tissue acidosis: A mechanism for inflammatory and ischemic myalgia?
53. Mediation of serotonin hyperalgesia by the cAMP second messenger system
54. Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia
55. The multiple dimensions of cancer pain: A framework for assessment and management
56. Growth curve analysis: A new approach for examining individual differences in symptoms
57. Individual differences in the experience of acute oral pain
58. Individual differences in severity of oral mucositis
59. Management of infection in patients with acute leukemia
60. New pathogens in neutropenic patients with cancer: An update for the new millennium
61. Bacteremia due to viridans streptococci in neutropenic patients: A review
62. Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors
63. Viridans streptococcal bacteremia in patients with haematological and solid malignancies
64. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors
65. The impact of mucositis on α-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematological malignancies
66. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: The pathogenetic role of the antileukemic regimen
67. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation
68. The 20 item Oral Mucositis Index: Reliability and validity in bone marrow and stem cell transplant patients
69. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis inducted by radiation or chemotherapy
70. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy
71. Randomized clinical trial to test the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis
72. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor β3
73. The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration
74. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients
75. Effect of granulocyte-macrophase colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation
76. Mucosal drug delivery
77. Human intestinal H+/peptide cotransporter: Cloning, functional expression, and chromosomal localization
78. Peptide mimics as substrates for the intestinal peptide transporter
79. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomized controlled trial comparing two protocols of dental care
80. Implementation of an oral care standard for leukemia and transplantation patients
81. Building and maintaining an interdisciplinary research team
82. Management of oral complications
83. Mucositis in head and neck cancer: Economic and quality-of-life outcomes
84. Oral mucositis and the clinical and economic outcomes of hematopoetic stem-cell transplantation
85. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis